4D Molecular Therapeutics(FDMT)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

FDMT 4D Molecular Therapeutics

盘前交易 05-20 06:57:53 EDT

25.34

-0.30

-1.17%

最高25.72	最低24.36	成交量43.87万
今开25.72	昨收25.64	日振幅5.30%
总市值13.10亿	流通市值7.83亿	总股本5,170万
成交额1,097万	换手率1.42%	流通股本3,088万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"FDMT","market":"US","secType":"STK","nameCN":"4D Molecular Therapeutics","latestPrice":25.34,"timestamp":1715976000000,"preClose":25.64,"halted":0,"volume":438654,"delay":0,"floatShares":30884583,"shares":51703412,"eps":-2.416519,"marketStatus":"盘前交易","marketStatusCode":1,"change":-0.3,"latestTime":"05-20 06:57:53 EDT","open":25.72,"high":25.72,"low":24.36,"amount":10968897.702432,"amplitude":0.053042,"askPrice":40.54,"askSize":200,"bidPrice":18.68,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-2.416519,"exchange":"NASDAQ","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1716211800000},"adr":0,"listingDate":1607662800000,"adjPreClose":25.34,"postHourTrading":{"tag":"盘后","latestPrice":25.34,"preClose":25.34,"latestTime":"19:37 EDT","volume":7851,"amount":198939.64,"timestamp":1715989059841},"volumeRatio":0.9239536137505777},"requestUrl":"/m/hq/s/FDMT/tweets","defaultTab":"tweets","newsList":[{"id":"2435519360","title":"4D Molecular Therapeutics, Inc.盘中异动 股价大涨5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2435519360","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2435519360?lang=zh_cn&edition=full","pubTime":"2024-05-14 21:33","pubTimestamp":1715693632,"startTime":"0","endTime":"0","summary":"北京时间2024年05月14日21时33分，4D Molecular Therapeutics, Inc.股票出现异动，股价大幅上涨5.01%。4D Molecular Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.08%。4D Molecular Therapeutics, Inc.公司简介：4D Molecular Therapeutics Inc 是一家临床阶段基因治疗公司，从事使用靶向和进化的AAV载体开发候选产品。该信息摘要如下：HC Wainwright & Co.：重申4D Molecular Therapeutics评级，由买入调整至买入评级, 目标价36.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024051421335279279e78&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024051421335279279e78&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2435375379","title":"4D Molecular Therapeutics, Inc.盘中异动 早盘大幅上涨5.57%报27.13美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2435375379","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2435375379?lang=zh_cn&edition=full","pubTime":"2024-05-13 21:52","pubTimestamp":1715608320,"startTime":"0","endTime":"0","summary":"北京时间2024年05月13日21时52分，4D Molecular Therapeutics, Inc.股票出现异动，股价急速拉升5.57%。4D Molecular Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.06%。4D Molecular Therapeutics, Inc.公司简介：4D Molecular Therapeutics Inc 是一家临床阶段基因治疗公司，从事使用靶向和进化的AAV载体开发候选产品。该信息摘要如下：HC Wainwright & Co.：重申4D Molecular Therapeutics评级，由买入调整至买入评级, 目标价36.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240513215200861ecd0d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240513215200861ecd0d&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2435695325","title":"HC Wainwright & Co.：重申4D Molecular Therapeutics(FDMT.US)评级，由买入调整至买入评级, 目标价36.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2435695325","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2435695325?lang=zh_cn&edition=full","pubTime":"2024-05-13 18:56","pubTimestamp":1715597769,"startTime":"0","endTime":"0","summary":"HC Wainwright & Co.：重申4D Molecular Therapeutics(FDMT.US)评级，由买入调整至买入评级, 目标价36.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405131856118b011614&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405131856118b011614&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2434855383","title":"美国研究综述-Cerence、Epam Systems、Progyny","url":"https://stock-news.laohu8.com/highlight/detail?id=2434855383","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2434855383?lang=zh_cn&edition=full","pubTime":"2024-05-10 20:39","pubTimestamp":1715344798,"startTime":"0","endTime":"0","summary":"    路透5月10日 - 华尔街证券分析师周五调整了对几家美国上市公司的评级和目标价，其中包括 Cerence、Epam Systems 和 Progyny。要闻  * Cerence Inc   ：富国银行将其评级从 \"增持 \"下调至 \"等权重\"。* Epam Systems Inc   ：丰业银行将其评级从 \"跑赢大市 \"下调至 \"行业表现\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2433226444","title":"4D Molecular Therapeutics Inc   预计每股亏损74美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2433226444","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2433226444?lang=zh_cn&edition=full","pubTime":"2024-05-06 20:10","pubTimestamp":1714997422,"startTime":"0","endTime":"0","summary":"   * 4D Molecular Therapeutics Inc    预计在5月8日公布截至2024年3月31日的业绩时，季度收入将出现增长(预计)    * 根据LSEG的数据，6位分析师的平均预期显示，这家总部位于加利福尼亚州埃默里维尔的公司的营收预计将从一年前的29.8万美元增至78.5万美元，增幅为163.4%。* LSEG 分析师对 4D Molecular Therapeutics Inc 的平均预期是每股亏损 74 美分。* 华尔街对 4D Molecular Therapeutics Inc 的 12 个月目标价中位数为 45.00 美元，高于其最新收盘价 26.38 美元。5月6日 - 上一季度业绩。除非另有说明，所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2432977092","title":"4D Molecular Therapeutics, Inc.盘中异动 早盘大幅拉升5.53%报27.84美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2432977092","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2432977092?lang=zh_cn&edition=full","pubTime":"2024-05-03 21:33","pubTimestamp":1714743214,"startTime":"0","endTime":"0","summary":"北京时间2024年05月03日21时33分，4D Molecular Therapeutics, Inc.股票出现异动，股价快速上涨5.53%。4D Molecular Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.15%。其相关个股中，Vaxxinity, Inc.、Ardelyx, Inc.、Jaguar Health, Inc.涨幅较大，Allarity Therapeutics, Inc.、Vaxxinity, Inc.、Jaguar Health, Inc.较为活跃，换手率分别为69.18%、22.21%、11.11%，振幅较大的相关个股有Rani Therapeutics Holdings, Inc.、Organovo Holdings, Inc.、Relay Therapeutics, Inc.，振幅分别为15.86%、15.78%、13.56%。4D Molecular Therapeutics, Inc.公司简介：4D Molecular Therapeutics Inc 是一家临床阶段基因治疗公司，从事使用靶向和进化的AAV载体开发候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240503213335861ead45&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240503213335861ead45&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2432835638","title":"4D Molecular Therapeutics, Inc.盘中异动 下午盘股价大涨5.06%报25.14美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2432835638","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2432835638?lang=zh_cn&edition=full","pubTime":"2024-05-02 02:06","pubTimestamp":1714586811,"startTime":"0","endTime":"0","summary":"北京时间2024年05月02日02时06分，4D Molecular Therapeutics, Inc.股票出现异动，股价急速上涨5.06%。4D Molecular Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.12%。其相关个股中，Cytomx Therapeutics, Inc.、Cyclacel Pharmaceuticals, Inc.、Aptevo Therapeutics Inc.涨幅较大，Palisade Bio, Inc.、Cyclacel Pharmaceuticals, Inc.、Cytomx Therapeutics, Inc.较为活跃，换手率分别为1401.54%、840.78%、249.77%，振幅较大的相关个股有Cytomx Therapeutics, Inc.、Cyclacel Pharmaceuticals, Inc.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 ，振幅分别为188.34%、84.43%、77.43%。4D Molecular Therapeutics, Inc.公司简介：4D Molecular Therapeutics Inc 是一家临床阶段基因治疗公司，从事使用靶向和进化的AAV载体开发候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050202065287e85358&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050202065287e85358&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2431628428","title":"4D Molecular Therapeutics, Inc.盘中异动 快速拉升5.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2431628428","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2431628428?lang=zh_cn&edition=full","pubTime":"2024-04-29 22:23","pubTimestamp":1714400632,"startTime":"0","endTime":"0","summary":"北京时间2024年04月29日22时23分，4D Molecular Therapeutics, Inc.股票出现异动，股价大幅上涨5.20%。4D Molecular Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.83%。其相关个股中，Nkgen Biotech Inc C/Wts 31/05/2028、Soleno Therapeutics, Inc.、Ginkgo Bioworks Holdings, Inc.涨幅较大，Zyversa Therapeutics, Inc.、Biodexa Pharmaceuticals Plc、Avenue Therapeutics, Inc.较为活跃，换手率分别为894.61%、35.93%、18.56%，振幅较大的相关个股有Cassava Sciences Inc C/Wts 15/11/2024、Zyversa Therapeutics, Inc.、Immunitybio, Inc.，振幅分别为33.33%、31.06%、29.01%。4D Molecular Therapeutics, Inc.公司简介：4D Molecular Therapeutics Inc 是一家临床阶段基因治疗公司，从事使用靶向和进化的AAV载体开发候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404292223527924f388&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404292223527924f388&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430868712","title":"4D Molecular Therapeutics, Inc.盘中异动 早盘急速下跌5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430868712","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2430868712?lang=zh_cn&edition=full","pubTime":"2024-04-25 21:37","pubTimestamp":1714052271,"startTime":"0","endTime":"0","summary":"北京时间2024年04月25日21时37分，4D Molecular Therapeutics, Inc.股票出现异动，股价大幅跳水5.07%。4D Molecular Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.02%。其相关个股中，Processa Pharmaceuticals, Inc.、Nrx Pharmaceuticals Inc C/Wts 24/05/2026 、Zura Bio Limited C/Wts 涨幅较大，Processa Pharmaceuticals, Inc.、Cyclacel Pharmaceuticals, Inc.、Cidara Therapeutics, Inc.较为活跃，换手率分别为877.70%、182.86%、7.06%，振幅较大的相关个股有Cassava Sciences Inc C/Wts 15/11/2024、Processa Pharmaceuticals, Inc.、凯信远达，振幅分别为40.85%、25.31%、14.75%。4D Molecular Therapeutics, Inc.公司简介：4D Molecular Therapeutics Inc 是一家临床阶段基因治疗公司，从事使用靶向和进化的AAV载体开发候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240425213752861e9096&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240425213752861e9096&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429430929","title":"4D Molecular Therapeutics, Inc.盘中异动 股价大涨6.60%报26.92美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2429430929","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2429430929?lang=zh_cn&edition=full","pubTime":"2024-04-22 21:30","pubTimestamp":1713792659,"startTime":"0","endTime":"0","summary":"北京时间2024年04月22日21时30分，4D Molecular Therapeutics, Inc.股票出现波动，股价急速上涨6.60%。截至发稿，该股报26.92美元/股，成交量2578股，换手率0.01%，振幅0.00%。4D Molecular Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.06%。4D Molecular Therapeutics, Inc.公司简介：4D Molecular Therapeutics Inc 是一家临床阶段基因治疗公司，从事使用靶向和进化的AAV载体开发候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404222131007a5491b4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404222131007a5491b4&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428344343","title":"4D Molecular Therapeutics, Inc.盘中异动 股价大跌5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2428344343","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428344343?lang=zh_cn&edition=full","pubTime":"2024-04-17 22:23","pubTimestamp":1713363835,"startTime":"0","endTime":"0","summary":"北京时间2024年04月17日22时23分，4D Molecular Therapeutics, Inc.股票出现波动，股价急速下挫5.08%。4D Molecular Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.78%。4D Molecular Therapeutics, Inc.公司简介：4D Molecular Therapeutics Inc 是一家临床阶段基因治疗公司，从事使用靶向和进化的AAV载体开发候选产品。该信息摘要如下：加拿大皇家银行：维持4D Molecular Therapeutics评级，由优于大市调整至优于大市评级, 目标价由35.00美元调整至40.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240417222355861e6bbf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240417222355861e6bbf&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427884660","title":"美国研究综述-Blackstone、Coupang、富国银行","url":"https://stock-news.laohu8.com/highlight/detail?id=2427884660","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2427884660?lang=zh_cn&edition=full","pubTime":"2024-04-16 01:46","pubTimestamp":1713203205,"startTime":"0","endTime":"0","summary":"    路透社4月15日 - 华尔街证券分析师周一调整了对几家美国上市公司的评级和目标价，其中包括黑石、Coupang 和富国银行。* Coupang Inc   ：花旗集团将其评级从中性上调至买入 * 联合太平洋公司  ：伯恩斯坦将其目标价从280美元上调至284美元 * 富国银行  ：Piper Sandler将目标价从56美元上调至61美元 以下是路透社周一报道的美国公司研究行动摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2427881280","title":"加拿大皇家银行：维持4D Molecular Therapeutics(FDMT.US)评级，由优于大市调整至优于大市评级, 目标价由35.00美元调整至40.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2427881280","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2427881280?lang=zh_cn&edition=full","pubTime":"2024-04-16 01:35","pubTimestamp":1713202544,"startTime":"0","endTime":"0","summary":"加拿大皇家银行：维持4D Molecular Therapeutics(FDMT.US)评级，由优于大市调整至优于大市评级, 目标价由35.00美元调整至40.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240416013548878097b6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240416013548878097b6&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427000687","title":"4D Molecular Therapeutics, Inc.盘中异动 早盘股价大涨5.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2427000687","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2427000687?lang=zh_cn&edition=full","pubTime":"2024-04-15 21:31","pubTimestamp":1713187862,"startTime":"0","endTime":"0","summary":"北京时间2024年04月15日21时31分，4D Molecular Therapeutics, Inc.股票出现异动，股价快速上涨5.20%。4D Molecular Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.77%。其相关个股中，Soligenix, Inc.、Organovo Holdings, Inc.、Longeveron Inc.涨幅较大，Allarity Therapeutics, Inc.、Soligenix, Inc.、Longeveron Inc.较为活跃，换手率分别为578.18%、335.34%、251.73%，振幅较大的相关个股有Organovo Holdings, Inc.、Soligenix, Inc.、Vaxxinity, Inc.，振幅分别为20.79%、16.32%、9.83%。4D Molecular Therapeutics, Inc.公司简介：4D Molecular Therapeutics Inc 是一家临床阶段基因治疗公司，从事使用靶向和进化的AAV载体开发候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404152131028b263edf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404152131028b263edf&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426128686","title":"4D Molecular Therapeutics, Inc.盘中异动 股价大跌5.08%报27.29美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2426128686","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426128686?lang=zh_cn&edition=full","pubTime":"2024-04-10 03:28","pubTimestamp":1712690908,"startTime":"0","endTime":"0","summary":"北京时间2024年04月10日03时28分，4D Molecular Therapeutics, Inc.股票出现异动，股价快速下跌5.08%。4D Molecular Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.40%。其相关个股中，Biocardia Inc C/Wts 06/08/2024、Acrivon Therapeutics, Inc.、Calidi Biotherapeutics, Inc.涨幅较大，Mymd Pharmaceuticals, Inc.、Acrivon Therapeutics, Inc.、Allarity Therapeutics, Inc.较为活跃，换手率分别为490.27%、163.98%、151.06%，振幅较大的相关个股有Calidi Biotherapeutics, Inc.、Nutriband Inc C/Wts 、Vbi Vaccines, Inc.，振幅分别为118.42%、87.27%、71.66%。4D Molecular Therapeutics, Inc.公司简介：4D Molecular Therapeutics Inc 是一家临床阶段基因治疗公司，从事使用靶向和进化的AAV载体开发候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041003282887e7eeed&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041003282887e7eeed&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2424904570","title":"4D Molecular Therapeutics, Inc.盘中异动 急速下挫5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2424904570","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2424904570?lang=zh_cn&edition=full","pubTime":"2024-04-02 21:31","pubTimestamp":1712064664,"startTime":"0","endTime":"0","summary":"北京时间2024年04月02日21时31分，4D Molecular Therapeutics, Inc.股票出现异动，股价急速下跌5.00%。4D Molecular Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.14%。其相关个股中，Aditxt, Inc.、Nrx Pharmaceuticals Inc C/Wts 24/05/2026 、Coeptis Therapeutics Holdings, Inc.涨幅较大，Aditxt, Inc.、Imunon, Inc.、Vbi Vaccines, Inc.较为活跃，换手率分别为368.29%、10.31%、9.18%，振幅较大的相关个股有Nrx Pharmaceuticals Inc C/Wts 24/05/2026 、Aptose Biosciences, Inc.、Affimed N.V.，振幅分别为48.62%、8.75%、8.66%。4D Molecular Therapeutics, Inc.公司简介：4D Molecular Therapeutics Inc 是一家临床阶段基因治疗公司，从事使用靶向和进化的AAV载体开发候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240402213105861e2fce&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240402213105861e2fce&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422084912","title":"4D Molecular Therapeutics, Inc.盘中异动 股价大涨5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2422084912","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2422084912?lang=zh_cn&edition=full","pubTime":"2024-03-27 23:45","pubTimestamp":1711554318,"startTime":"0","endTime":"0","summary":"北京时间2024年03月27日23时45分，4D Molecular Therapeutics, Inc.股票出现异动，股价快速拉升5.11%。4D Molecular Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.13%。其相关个股中，Ibio, Inc.、Moolec Science Sa C/Wts 、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 涨幅较大，Ibio, Inc.、Lixte Biotechnology Holdings, Inc.、Gamida Cell Ltd.较为活跃，换手率分别为3112.06%、1177.40%、66.92%，振幅较大的相关个股有Ibio, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Stoke Therapeutics, Inc.，振幅分别为86.96%、78.00%、58.70%。4D Molecular Therapeutics, Inc.公司简介：4D Molecular Therapeutics Inc 是一家临床阶段基因治疗公司，从事使用靶向和进化的AAV载体开发候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240327234519861e1b8d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240327234519861e1b8d&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2421477710","title":"4D Molecular Therapeutics, Inc.盘中异动 下午盘股价大涨5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2421477710","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2421477710?lang=zh_cn&edition=full","pubTime":"2024-03-21 02:52","pubTimestamp":1710960766,"startTime":"0","endTime":"0","summary":"北京时间2024年03月21日02时52分，4D Molecular Therapeutics, Inc.股票出现异动，股价快速拉升5.03%。4D Molecular Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.31%。其相关个股中，Xtl生物制药、Estrella Immunopharma Inc C/Wts 29/09/2028、Surrozen Inc C/Wts 01/08/2031 涨幅较大，Xtl生物制药、Jaguar Health, Inc.、Tc Biopharm  Plc较为活跃，换手率分别为212.76%、87.70%、46.72%，振幅较大的相关个股有Xtl生物制药、Nls Pharmaceutics Ltd.、Igc Pharma, Inc.，振幅分别为157.69%、83.33%、43.55%。4D Molecular Therapeutics, Inc.公司简介：4D Molecular Therapeutics Inc 是一家临床阶段基因治疗公司，从事使用靶向和进化的AAV载体开发候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403210252467a4dff35&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403210252467a4dff35&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2419977940","title":"4D Molecular Therapeutics, Inc.盘中异动 股价大涨5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2419977940","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2419977940?lang=zh_cn&edition=full","pubTime":"2024-03-15 21:48","pubTimestamp":1710510532,"startTime":"0","endTime":"0","summary":"北京时间2024年03月15日21时48分，4D Molecular Therapeutics, Inc.股票出现异动，股价大幅拉升5.11%。4D Molecular Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.07%。其相关个股中，Better Therapeutics, Inc.、杰龙、Jasper Therapeutics Inc C/Wts 24/09/2026 涨幅较大，Better Therapeutics, Inc.、Galmed Pharmaceuticals Ltd.、知临集团较为活跃，换手率分别为188.50%、67.26%、13.31%，振幅较大的相关个股有Better Therapeutics, Inc.、Sab Biotherapeutics Inc C/Wts 22/10/2026 、联拓生物，振幅分别为84.57%、63.00%、49.00%。4D Molecular Therapeutics, Inc.公司简介：4D Molecular Therapeutics Inc 是一家临床阶段基因治疗公司，从事使用靶向和进化的AAV载体开发候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403152148527a4d14bc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403152148527a4d14bc&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2417505340","title":"4D Molecular Therapeutics, Inc.盘中异动 急速上涨5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2417505340","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2417505340?lang=zh_cn&edition=full","pubTime":"2024-03-08 22:30","pubTimestamp":1709908243,"startTime":"0","endTime":"0","summary":"北京时间2024年03月08日22时30分，4D Molecular Therapeutics, Inc.股票出现波动，股价急速上涨5.05%。4D Molecular Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Psyence Biomedical Ltd.、Psyence Biomedical Ltd C/Wts 25/01/2029、Cero Therapeutics Holdings, Inc.涨幅较大，Scisparc Ltd.、Psyence Biomedical Ltd.、Quoin Pharmaceuticals Ltd较为活跃，换手率分别为201.51%、184.58%、167.72%，振幅较大的相关个股有Denali Therapeutics Inc.、Cellectis Ads Each Repr 1 Ord Spon、Elicio Therapeutics, Inc.，振幅分别为4.99%、4.78%、4.47%。4D Molecular Therapeutics, Inc.公司简介：4D Molecular Therapeutics Inc是一家临床阶段的基因治疗公司，从事使用靶向和进化的AAV载体开发候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403082230437a4adf3e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403082230437a4adf3e&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.4dmoleculartherapeutics.com","stockEarnings":[{"period":"1week","weight":-0.014},{"period":"1month","weight":0.0016},{"period":"3month","weight":-0.0704},{"period":"6month","weight":1.0788},{"period":"1year","weight":0.4373},{"period":"ytd","weight":0.2507}],"compareEarnings":[{"period":"1week","weight":0.0165},{"period":"1month","weight":0.0577},{"period":"3month","weight":0.0599},{"period":"6month","weight":0.1745},{"period":"1year","weight":0.2629},{"period":"ytd","weight":0.1139}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"4D Molecular Therapeutics, Inc.于2015年3月11日根据特拉华州法律成立。该公司是一家临床阶段基因治疗公司，开创了利用其靶向和进化的AAV载体开发候选产品的先河。","yearOnYearQuotes":[{"month":1,"riseRate":0.25,"avgChangeRate":-0.114674},{"month":2,"riseRate":0.25,"avgChangeRate":0.09912},{"month":3,"riseRate":0.75,"avgChangeRate":0.041874},{"month":4,"riseRate":0.25,"avgChangeRate":-0.130346},{"month":5,"riseRate":0.5,"avgChangeRate":-0.149515},{"month":6,"riseRate":0,"avgChangeRate":-0.063179},{"month":7,"riseRate":1,"avgChangeRate":0.130747},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.015275},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.104114},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.06274},{"month":11,"riseRate":0.666667,"avgChangeRate":0.644163},{"month":12,"riseRate":0.333333,"avgChangeRate":0.155196}],"exchange":"NASDAQ","name":"4D Molecular Therapeutics","nameEN":"4D Molecular Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"4D Molecular Therapeutics(FDMT)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供4D Molecular Therapeutics(FDMT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"4D Molecular Therapeutics,FDMT,4D Molecular Therapeutics股票,4D Molecular Therapeutics股票老虎,4D Molecular Therapeutics股票老虎国际,4D Molecular Therapeutics行情,4D Molecular Therapeutics股票行情,4D Molecular Therapeutics股价,4D Molecular Therapeutics股市,4D Molecular Therapeutics股票价格,4D Molecular Therapeutics股票交易,4D Molecular Therapeutics股票购买,4D Molecular Therapeutics股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"4D Molecular Therapeutics(FDMT)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供4D Molecular Therapeutics(FDMT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}